TipRanks

Luke Nathaniel Walker Insider Profile

11 Followers
Luke Nathaniel Walker, Director at Context Therapeutics, holds ― shares in Context Therapeutics (Ticker: CNTX), holds 201.38K shares in Zentalis Pharmaceuticals (Ticker: ZNTL), holds 0.00 shares in Harpoon Therapeutics (Ticker: HARP). Most recently, Luke Nathaniel Walker ― shares of Context Therapeutics on ― for an estimated value of ―.
tipranks
Luke Nathaniel Walker

Luke Nathaniel Walker
Context Therapeutics (CNTX)
Director

Not Ranked
Luke Nathaniel Walker has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$507K
100.00%
0.00%
A breakdown of Luke Nathaniel Walker's holdings

Insider Roles

Zentalis Pharmaceuticals
(ZNTL)
Director
Context Therapeutics
(CNTX)
Director
Roles that Luke Nathaniel Walker holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Luke Nathaniel Walker

Luke Nathaniel Walker's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Context Therapeutics
―
Director
―
―
CASC
Cascadian Therapeutics
Mar 13, 2018
―
Uninformative Sell
―
$0.00
HARP
Harpoon Therapeutics
Mar 11, 2024
―
Uninformative Sell
―
$0.00
Zentalis Pharmaceuticals
Jun 18, 2026
Director
Uninformative Buy
―
$507.49K
List of latest transactions for each holding click on a transaction to see Luke Nathaniel Walker's performance on stock

Luke Nathaniel Walker insider profile FAQ

What is the percentage of profitable transactions made by Luke Nathaniel Walker?
The percentage of profitable transactions made by Luke Nathaniel Walker is ―.
    What is the average return per transaction made by Luke Nathaniel Walker?
    The average return per transaction made by Luke Nathaniel Walker is ―.
      What stocks does Luke Nathaniel Walker hold?
      Luke Nathaniel Walker holds: CNTX, CASC, HARP, ZNTL stocks.
        What was Luke Nathaniel Walker’s latest transaction?
        Luke Nathaniel Walker latest transaction was an Uninformative Buy of ―.
          What was Luke Nathaniel Walker's most profitable transaction?
          Luke Nathaniel Walker’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Luke Nathaniel Walker's role in Context Therapeutics?
            Luke Nathaniel Walker's role in Context Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.